Table 2.
Group | Gender (%) | Age | Weight | Diagnosis | Ecog Ps | Stage |
---|---|---|---|---|---|---|
Controls (n = 95) | males = 55% | 56.34 ± 0.677 (95*) | 76.73 ± 1.58 (93*) | Healthy subjects (n = 75) | 0 (100%) | NV |
females = 45% | Patients suffering from non-neoplastic diseases# (n = 20) | 0 (100%) | NV | |||
Oncologic patients (n = 186) | males = 59% | 65.27 ± 0.877 (186*) | 74.00 ± 1.92 (186*) | Carcinoma (n = 178) | 0–1 (38%) 2–3 (62%) |
I –IIIA 20% IIIB– IV 80% |
females = 41% | Mesothelioma, and sarcoma (n = 8) |
Results are mean ± S.D and n (the number of patients and controls in parentheses,
indicates the number depending of missing data).
asthma, hypertension, allergic rhinitis, muscle pain, high cholesterol levels.